“When the Covid-19 pandemic hit the US, young biotech company Verve Therapeutics was only months away from a pivotal development: studies in animals of its approach to gene processing to lower cholesterol that would lead to heralding as potential” cure for heart disease. “ Mar Chief Executive Dr. Sekar Kathiresan …
Read More »This biotech CEO calculated Covid tests for 50 companies with 12-hour turnaround
